Skip to Main Content

Table 3. Incidence of Adverse Events after Administration of Immediate- and Sustained-release Hydromorphone, and Placebo

Side effects were of mild severity until noted differently by the number in parentheses, indicating the incidence that a particular side effect was of moderate severity.

*P < 0.05, 32 mg SRH versus  placebo.

IRH = immediate-release hydromorphone; SRH = sustained-release hydromorphone.

Table 3. Incidence of Adverse Events after Administration of Immediate- and Sustained-release Hydromorphone, and Placebo
Table 3. Incidence of Adverse Events after Administration of Immediate- and Sustained-release Hydromorphone, and Placebo
Close Modal

or Create an Account

Close Modal
Close Modal